United Therapeutics — Drug Prices & Medicare Spending
United Therapeutics manufactures 3 drugs tracked by Medicare Part D with total spending of $2.7B.
3
Drugs Tracked
$2.7B
Medicare Spending
$16,731.25
Avg Cost/Claim
100%
Have Generics
United Therapeutics Drugs — Ranked by Medicare Spending
| # | Drug | Generic Name | Cost/Claim | Generic? |
|---|---|---|---|---|
| 1 | Tyvaso | Treprostinil (inhaled) | $14,349.00 | Yes |
| 2 | Remodulin | Treprostinil (SC/IV) | $20,857.00 | Yes |
| 3 | Orenitram | Treprostinil (oral) | $17,719.00 | Yes |
Frequently Asked Questions
United Therapeutics manufactures 3 drugs tracked by Medicare Part D, with total annual spending of $2.7B.
Remodulin (Treprostinil (SC/IV)) is the most expensive at $20,857.00 per claim.
3 of 3 United Therapeutics drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.